会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Ondansetron orally disintegrating tablets
    • 昂丹司琼口服崩解片
    • US07390503B1
    • 2008-06-24
    • US10923021
    • 2004-08-23
    • Salah U. AhmedSudhir R. GorukantiTahseen A. Chowdhury
    • Salah U. AhmedSudhir R. GorukantiTahseen A. Chowdhury
    • A61K9/20A61K9/14A61K9/50
    • A61K9/0056A61K9/2018A61K9/2027A61K9/2054
    • An ondansetron solid orally disintegrating dosage form for oral administration having at least one first water-dispersible component or water-insoluble cellulose derivative, a component having a —CHOH functional group, a disintegrating agent and at least one lubricant is provided. The dosage form can comprise ondansetron, a hydrophilic polymer such as microcrystalline cellulose, a component having a —CHOH functional group such as mannitol or xylitol and a disintegrating agent such as crospovidone. The lubricant may be a mixture of magnesium stearate, sodium stearyl fumarate and colloidal silicon dioxide. The present invention provides a non-effervescent tablet comprising the ondansetron dosage form. Another aspect of the invention is the treatment of emesis such as nausea and vomiting caused by cancer chemotherapy and radiation by the administration of the ondansetron formulation of the present composition. Finally, a process of forming an ondansetron disintegrating tablet using the ondansetron dosage form is disclosed.
    • 提供了具有至少一种第一水分散性成分或水不溶性纤维素衍生物,具有-CHOH官能团的成分,崩解剂和至少一种润滑剂的口服的昂丹司琼固体口腔崩解剂型。 剂型可以包含昂丹司琼,亲水性聚合物如微晶纤维素,具有-CHOH官能团的组分如甘露醇或木糖醇和崩解剂如交聚维酮。 润滑剂可以是硬脂酸镁,硬脂酰富马酸钠和胶体二氧化硅的混合物。 本发明提供了包含昂丹司琼剂型的非泡腾片剂。 本发明的另一方面是通过施用本发明组合物的昂丹司琼制剂来治疗呕吐,例如由癌症化疗和放射引起的恶心和呕吐。 最后,公开了使用昂丹司琼剂型形成昂丹司琼崩解片的方法。